financetom
Business
financetom
/
Business
/
Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion
Nov 4, 2025 6:34 AM

Nov 4 (Reuters) - Novo Nordisk is now

offering up to $10 billion for Metsera ( MTSR ), up from its

prior offer of up to $8.5 billion, the obesity drug developer

said on Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UniCredit CEO says digital euro
UniCredit CEO says digital euro "very good" plan if banks fully involved
Jun 18, 2024
MILAN, June 18 (Reuters) - Plans for a digital euro will be a very good thing for the currency bloc and its lenders if banks remain central to the flow of money as they are at present, UniCredit Chief Executive Andrea Orcel said on Tuesday. It's a matter of sovereignty for Europe: we cannot not have a digital euro, Orcel...
What's Going On With Greenwave Technology
What's Going On With Greenwave Technology
Jun 18, 2024
Greenwave Technology Solutions, Inc. ( GWAV ) shares are trading higher Tuesday after the company announced the completion of its recapitalization. The Details: Greenwave said it has strengthened its balance sheet by approximately $80.5 million since February and has a current cash balance of over $26 million, its strongest cash position in company history.  The company also said it is...
Lexaria Bioscience Hires Contract Research Organization For 12-week Study
Lexaria Bioscience Hires Contract Research Organization For 12-week Study
Jun 18, 2024
11:40 AM EDT, 06/18/2024 (MT Newswires) -- Lexaria Bioscience ( LEXX ) said Tuesday that it hired a contract research organization to manage its 12-week chronic study, GLP-1-H24-4, to evaluate different DehydraTECH-GLP-1 formulations and other treatments, focusing on goals such as weight loss and reducing blood sugar levels. Preparations for the study with the CRO have started under an initial...
What's Going On With Mustang Bio Stock Tuesday?
What's Going On With Mustang Bio Stock Tuesday?
Jun 18, 2024
Mustang Bio, Inc. ( MBIO ) shares appear to be trending upward Tuesday on continued momentum after the company on Monday announced safety and efficacy data from its Phase 1/2 clinical trial of MB-106, a possible treatment for certain types of blood cancer. 90% of patients treated with MB-106 responded to the treatment with three complete responses. Out of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved